SCHEMBL19852617

SCHEMBL19852617

CN1C(=O)c2cccc(-n3c4ccccc4c4cc(-c5cncnc5)ccc43)c2C1=O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 4/20 0.36
▸ KMT2A Q03164 4/20 0.36
▸ CASP1 P29466 2/20 0.36
▸ USP2 O75604 2/20 0.36
▸ BRCA1 P38398 1/20 0.36
▸ CASP7 P55210 1/20 0.36
▸ NPY5R Q15761 1/20 0.35
▸ PRKDC P78527 2/20 0.35
▸ DUSP3 P51452 1/20 0.34
▸ TNIK Q9UKE5 1/20 0.34
▸ CASP3 P42574 1/20 0.34
▸ POLB P06746 1/20 0.34
▸ TTR P02766 1/20 0.33
▸ CES1 P23141 1/20 0.33
▸ PADI4 Q9UM07 1/20 0.33
▸ PDE10A Q9Y233 2/20 0.33
▸ BTK Q06187 1/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ HPGD P15428 2/20 0.33
▸ MAPT P10636 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20978693 0.96 MEN1 (0.39) MEN1KMT2ACASP1USP2BRCA1
SCHEMBL23515988 0.94 MEN1 (0.36) MEN1KMT2ACASP1USP2BRCA1
SCHEMBL23516508 0.89 CYP11B2 (0.43) —
SCHEMBL23516097 0.89 MAPK14 (0.41) NPY5RDUSP3CASP3BRD4
SCHEMBL23515987 0.86 DUSP3 (0.42) MEN1KMT2ACASP1USP2BRCA1
SCHEMBL23516327 0.86 HSPA1A (0.41) MEN1KMT2AUSP2DUSP3POLB
SCHEMBL19850052 0.85 TYMS (0.41) MEN1KMT2APRKDCDUSP3POLB
SCHEMBL23516170 0.85 MEN1 (0.38) MEN1KMT2ACASP1USP2BRCA1
SCHEMBL19843010 0.85 TYMS (0.36) MEN1KMT2APRKDCDUSP3POLB
SCHEMBL19842971 0.85 PDE6D (0.41) MEN1KMT2AUSP2PRKDCDUSP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11276825-B2 Organic molecules for use in organic devices CYNORA GMBH (DE) 2022-03-15 — — US disclosed
US-20210184134-A1 ORGANIC MOLECULES FOR USE IN ORGANIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2021-06-17 — — US disclosed
EP-3279193-B1 COMPOUNDS COMPRISING A PHTHALIMIDE GROUP AND CARBAZOLE OR ITS ANALOGUES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2019-05-08 — — EP disclosed
WO-2018024723-A1 PHTHALIMIDE AND CARBAZOLE OR ANALOGS THEREOF CONTAINING COMPOUNDS FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-02-08 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210184134-A1 ORGANIC MOLECULES FOR USE IN ORGANIC DEVICES CHRM1, C1S, DNMT3L MEN1 887/4885KMT2A 1260/4885CASP1 2883/4885
US-11276825-B2 Organic molecules for use in organic devices AOX1, OR10J3, L1CAM MEN1 2728/4885KMT2A 4062/4885CASP1 1720/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback